Please use this identifier to cite or link to this item: http://hdl.handle.net/10362/97244
Title: Tofacitinib synthesis – An asymmetric challenge
Author: Carvalho, Luísa C. R.
Lourenço, Ana
Ferreira, Luísa Maria
Branco, Paula Sério
Keywords: Asymmetric synthesis
Chiral resolution
Nitrogen heterocycles
Piperidine rings
Tofacitinib
Physical and Theoretical Chemistry
Organic Chemistry
Issue Date: 2019
Citation: Carvalho, L. C. R., Lourenço, A., Ferreira, L. M., & Branco, P. S. (2019). Tofacitinib synthesis – An asymmetric challenge. European Journal of Organic Chemistry, 2019(4), 615-624. https://doi.org/10.1002/ejoc.201801180
Abstract: Tofacitinib is a Janus activated kinase (JAK) inhibitor approved for the treatment of rheumatoid arthritis and active psoriatic arthritis. Its synthesis normally involves long synthetic sequences due to the chirality associated to the piperidine ring. This review is a comprehensive analysis of the different synthetic methods used to prepare this active pharmaceutical ingredient (API), covering the related journal and patent literature.
Description: co-financed by the ERDF under the PT2020 Partnership Agreement (POCI-01-0145-FEDER-007265). The authors would like to thank Hovione FarmaCiencia SA for financial support.
Peer review: yes
URI: http://hdl.handle.net/10362/97244
DOI: https://doi.org/10.1002/ejoc.201801180
ISSN: 1434-193X
Appears in Collections:FCT: DQ - Artigos em revista internacional com arbitragem científica

Files in This Item:
File Description SizeFormat 
carvalho2018.pdf2,46 MBAdobe PDFView/Open


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote 

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.